Wegovy Helps HFpEF Patients With Diabetes Mellitus Weight and symptoms improved in STEP-HFpEF DM trial Apr 07, 2024
Weight-Loss Drug Zepbound Faces Supply Issues Following weight-loss indication, patients struggle to obtain tirzepatide Apr 02, 2024
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes? News and commentary from the endocrinology world Apr 02, 2024
Man With Chainsaw Assaults Hospital Staff; Havana Syndrome Case; Ozempic at Costco Health news and commentary from around the Web gathered by ľֱ staff Apr 02, 2024
GLP-1 Users May Have Increased Endoscopy-Related Aspiration Pneumonia Risk Overall incidence is still low, however Apr 01, 2024
Need 10,000 Daily Steps to Prevent Obesity? It May Depend on Genetics Current recommendations may underestimate activity needs for people with high genetic risk Mar 27, 2024
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? News and commentary from the endocrinology world Mar 26, 2024
Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients News comes in the wake of FDA approval to reduce risk of heart attacks, stroke Mar 21, 2024
Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? News and commentary from the endocrinology world Mar 19, 2024
FDA Approves First-Ever Drug for Serious Liver Condition Resmetirom indicated for NASH patients with liver scarring Mar 14, 2024
Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes News and commentary from the endocrinology world Mar 12, 2024
Online Obesity Program Helped Primary Care Patients Lose Weight Weight regain was less in the groups who participated in 9 months of active maintenance Mar 11, 2024
Deaths Due to Alcohol Use; Steps for the Sedentary Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
Cardiometabolic Disorders Tend to Accompany a 'Lazy Eye' Persistent amblyopia associated with myocardial infarction and death Mar 08, 2024
Wegovy Approved for Major Heart Disease Prevention New indication for patients with obesity or overweight and a history of cardiovascular disease Mar 08, 2024
Obesity Drugs Like Wegovy Are Meant for Long-Term Use, but Some Want to Stop Other patients have been forced to ration or halt doses due to drug costs Mar 08, 2024
One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia? Even following this rule, increased residual gastric content still prevalent Mar 07, 2024
10,000 Steps Lowers Death Risk; Obesity Drug Beats Wegovy; Lead in Cinnamon Warning Health news and commentary from around the Web gathered by ľֱ staff Mar 07, 2024
Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D News and commentary from the endocrinology world Mar 05, 2024
Biden's Physical Results; Weight Loss Implant Tested; Richard Lewis Dies Health news and commentary from around the Web gathered by ľֱ staff Feb 29, 2024
Abdominal Fat and Dementia; Mask Ban Lawsuit Tossed; FDA Rejects Psych Drug Health news and commentary from around the Web gathered by ľֱ staff Feb 28, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals News and commentary from the endocrinology world Feb 20, 2024
Bariatric Surgery Tied to Long-Term Cognitive Benefits Surgical weight loss linked with improved cognitive function, mood, and brain parameters on MRI Feb 12, 2024
Rapid Weight Loss a Diabetic Retinopathy Risk? While research is conflicting, GLP-1 therapies might cause transient worsening of retinal disease Feb 12, 2024
Ex-Doctor Charged With Manslaughter; NIH Subpoenaed; Social Cost of Obesity Drugs Health news and commentary from around the Web gathered by ľֱ staff Feb 07, 2024
More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk News and commentary from the endocrinology world Feb 06, 2024
Tirzepatide's Association With BP Reduction Reinforced With ABPM Data Combination GLP-1/GIP receptor agonist is currently approved for T2D and weight loss Feb 05, 2024
Durable Weight Loss Follows Just a Few Injections of Novel Drug Most of the body weight reduction persisted 150 days after the last dose in an early-phase trial Feb 05, 2024
U.S. Officials Call for More Programs, Education to Improve Diets in America More research on "gut-brain axis" is also needed Feb 02, 2024
Alleged Lewd Doc Acquitted; AI Detects Guns at Hospital; Obesity Bill of Rights Health news and commentary from around the Web gathered by ľֱ staff Feb 01, 2024
Perioperative Complications Not Deciding Factor Between Two Bariatric Procedures Short-term complications and safety similar for sleeve gastrectomy and RYGB Jan 30, 2024
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? News and commentary from the endocrinology world Jan 23, 2024
Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain News and commentary from the endocrinology world Jan 16, 2024
How Should Health Plans Respond to Surging Interest in Weight Loss Drugs? Studies suggest coverage is warranted for certain populations Jan 16, 2024
FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now Preliminary evaluation reassures, while the agency's review continues Jan 11, 2024
More Kids Getting Their Hands on Nonprescription Weight-Loss Products Almost 10% of kids said they've tried at least one drug or dietary supplement in their lifetime Jan 10, 2024
T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win News and commentary from the endocrinology world Jan 09, 2024
